ATE522815T1 - Mittel und verfahren zur prognose von nierenversagen bei diabetikern auf basis des plazentalen wachstumsfaktors und löslichem flt-1 - Google Patents
Mittel und verfahren zur prognose von nierenversagen bei diabetikern auf basis des plazentalen wachstumsfaktors und löslichem flt-1Info
- Publication number
- ATE522815T1 ATE522815T1 AT08156083T AT08156083T ATE522815T1 AT E522815 T1 ATE522815 T1 AT E522815T1 AT 08156083 T AT08156083 T AT 08156083T AT 08156083 T AT08156083 T AT 08156083T AT E522815 T1 ATE522815 T1 AT E522815T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- growth factor
- placental growth
- kidney failure
- persons based
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 title abstract 2
- 102100035194 Placenta growth factor Human genes 0.000 title abstract 2
- 208000001647 Renal Insufficiency Diseases 0.000 title abstract 2
- 201000006370 kidney failure Diseases 0.000 title abstract 2
- 108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 title 1
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/515—Angiogenesic factors; Angiogenin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08156083A EP2120051B1 (de) | 2008-05-13 | 2008-05-13 | Mittel und Verfahren zur Prognose von Nierenversagen bei Diabetikern auf Basis des plazentalen Wachstumsfaktors und löslichem Flt-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE522815T1 true ATE522815T1 (de) | 2011-09-15 |
Family
ID=39709041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08156083T ATE522815T1 (de) | 2008-05-13 | 2008-05-13 | Mittel und verfahren zur prognose von nierenversagen bei diabetikern auf basis des plazentalen wachstumsfaktors und löslichem flt-1 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8440463B2 (de) |
| EP (1) | EP2120051B1 (de) |
| JP (1) | JP2011520115A (de) |
| AT (1) | ATE522815T1 (de) |
| WO (1) | WO2009138364A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106361289A (zh) * | 2016-09-30 | 2017-02-01 | 重庆工商大学 | 一种慢性肾衰竭预警系统 |
| US11350887B2 (en) | 2019-08-07 | 2022-06-07 | Fresenius Medical Care Holdings, Inc. | Systems and methods for detection of potential health issues |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| CA2511269A1 (en) * | 2004-07-07 | 2006-01-07 | F. Hoffmann-La Roche Ag | Multimarker panel based on p1gf for diabetes type 1 and 2 |
| EP1615036B1 (de) | 2004-07-07 | 2007-09-19 | F.Hoffmann-La Roche Ag | Kombination von Markern für Diabetes Typ 1 und 2 |
| DE102004051847B4 (de) * | 2004-10-25 | 2008-09-18 | Dade Behring Marburg Gmbh | Verhältnis von PIGF und Flt-1 als prognostischer Parameter bei kardio-vaskulären Erkrankungen |
-
2008
- 2008-05-13 AT AT08156083T patent/ATE522815T1/de not_active IP Right Cessation
- 2008-05-13 EP EP08156083A patent/EP2120051B1/de not_active Not-in-force
-
2009
- 2009-05-08 JP JP2011507937A patent/JP2011520115A/ja active Pending
- 2009-05-08 WO PCT/EP2009/055595 patent/WO2009138364A2/en active Application Filing
-
2010
- 2010-10-21 US US12/909,140 patent/US8440463B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2120051A1 (de) | 2009-11-18 |
| EP2120051B1 (de) | 2011-08-31 |
| WO2009138364A2 (en) | 2009-11-19 |
| US8440463B2 (en) | 2013-05-14 |
| JP2011520115A (ja) | 2011-07-14 |
| WO2009138364A3 (en) | 2010-01-21 |
| US20110033942A1 (en) | 2011-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE493649T1 (de) | Verfahren zur diagnose von polyzystischer nierenkrankheit | |
| ATE514091T1 (de) | Verwendung von procalcitonin (pct) zur risikostratifikation und prognose bei patienten mit einer primären nichtinfektiösen krankheit | |
| DE602005027862D1 (de) | Polymer auf basis von polysaccharide für gewebekleber zur medizinischen verwendung | |
| ATE511656T1 (de) | Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis | |
| WO2007044860A3 (en) | Diabetes-associated markers and methods of use thereof | |
| DE602007011588D1 (de) | MITTEL UND VERFAHREN ZUR PROGNOSE ODER DIAGNOSE VON DIABETES Typ II | |
| ATE528410T1 (de) | Verfahren und zusammensetzungen zur diagnose von altersbedingter maculadegeneration | |
| WO2012018535A3 (en) | Wellness panel | |
| NO20074515L (no) | Fremgangsmate til prognose for mentale sykdommer, f.eks. autisme og cerebral parese | |
| WO2007032876A3 (en) | Biomarkers associated with age-related macular degeneration | |
| WO2008152656A3 (en) | Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma | |
| JP2014526676A5 (de) | ||
| ATE537454T1 (de) | Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 | |
| WO2011028912A3 (en) | A biomarker for neurodegeneration in neurological disease | |
| DE602006017058D1 (de) | Verfahren zur stratifizierung von herzinsuffizienz | |
| WO2006138292A3 (en) | Ratiometric test strip and method | |
| WO2010138610A3 (en) | Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease | |
| ATE518139T1 (de) | Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers | |
| ATE374367T1 (de) | Verwendung von cyanin-farbstoffen zur diagnose von krankheiten, welche mit angiogenese assoziert sind | |
| ATE522815T1 (de) | Mittel und verfahren zur prognose von nierenversagen bei diabetikern auf basis des plazentalen wachstumsfaktors und löslichem flt-1 | |
| ATE433115T1 (de) | Timp-2 als ziel/marker des versagens von beta- zellen | |
| ATE487947T1 (de) | Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse | |
| WO2008067806A3 (de) | Diagnose und risikostratifizierung von herzinsuffizienz mittels neurophysin | |
| WO2006117688A3 (en) | Diagnosis of heart failure | |
| DE602005015623D1 (de) | Ils mit flexiblem lokalem bereich, z.b. zur verwendung als innenausstattung für ein kraftfahrzeug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |